The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase.
The function of the human papillomavirus (HPV) E6 protein that is most clearly linked to carcinogenesis is the targeted degradation of p53, which is dependent on the E6AP ubiquitin ligase. Additional functions have been attributed to E6, including the stimulation of telomerase activity and the targeted degradation of other cellular proteins, but in most cases it is unclear whether these activities are also E6AP dependent. While E6 clearly influences the transcriptional program of HPV-positive cell lines through the inactivation of p53, it has been shown that at least a subset of its p53-independent functions are also reflected in the transcriptional program. For this study, we have determined the extent to which E6AP is involved in mediating the set of E6 functions that impact on the global transcriptional program of HPV-positive cell lines. The transcriptional profiles of approximately 31,000 genes were characterized for three cell lines (HeLa, Caski, and SiHa cells) after small interfering RNA (siRNA)-mediated silencing of E6 or E6AP. We found that E6 and E6AP siRNAs elicited nearly identical alterations in the transcriptional profile of each cell line. Some of the expression alterations were apparent secondary effects of p53 stabilization, while the basis of most other changes was not reconcilable with previously proposed E6 functions. While expression changes of the TERT gene (telomerase catalytic subunit) were not revealed by the array, telomerase repeat amplification protocol assays showed that both E6 and E6AP knockouts resulted in a suppression of telomerase activity. Together, these results suggest that E6AP mediates a broad spectrum of E6 functions, including virtually all functions that impact on the transcriptional program of HPV-positive cell lines.
Kelley
Melissa L
ML
Institute for Cellular and Molecular Biology, Section of Molecular Genetics and Microbiology, University of Texas at Austin, Austin, TX 78712, USA.
Keiger
Kerri E
KE
Lee
Chan Jae
CJ
Huibregtse
Jon M
JM
D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000502:physiology*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D020868:Gene Silencing; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000502:physiology*; D027383:Papillomaviridae / Q000502:physiology*; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000502:physiology*; D019098:Telomerase / Q000096:biosynthesis / Q000235:genetics; D014158:Transcription, Genetic; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis / Q000235:genetics; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
D004268:DNA-Binding Proteins; C068651:E6 protein, Human papillomavirus type 16; C052603:E6 protein, Human papillomavirus type 18; D009856:Oncogene Proteins, Viral; D034741:RNA, Small Interfering; D012097:Repressor Proteins; D016159:Tumor Suppressor Protein p53; C471639:UBE3A protein, human; D044767:Ubiquitin-Protein Ligases; C509186:TERT protein, human; D019098:Telomerase
Curr Opin Cell Biol. 2002 Dec;14(6):684-91
12473340
Annu Rev Biochem. 2003;72:783-812
14527327
Oncogene. 1999 Oct 14;18(42):5727-37
10523853
Mol Cell Biol. 1993 Aug;13(8):4918-27
8393140
Nat Rev Mol Cell Biol. 2003 Mar;4(3):192-201
12612638
J Virol. 2001 Aug;75(16):7583-91
11462030
Bioessays. 2003 Jun;25(6):542-53
12766944
J Virol. 1998 May;72(5):3925-34
9557678
EMBO J. 1999 Sep 15;18(18):5061-72
10487758
Oncogene. 1999 Sep 30;18(40):5487-96
10523825
Genes Dev. 2004 Sep 15;18(18):2269-82
15371341
EMBO J. 1986 Sep;5(9):2285-92
3023067
Cancer Res. 2002 Jun 1;62(11):3315-21
12036950
J Gen Virol. 1990 May;71 ( Pt 5):1243-6
2161056
Oncogene. 1998 Dec 10;17(23):2943-54
9881696
Science. 1995 Jul 28;269(5223):529-31
7624774
Virology. 2003 Sep 15;314(1):196-205
14517073
Oncogene. 2000 Feb 10;19(6):719-25
10698489
Cell. 1993 Nov 5;75(3):495-505
8221889
Science. 2000 Jul 7;289(5476):113-6
10884224
J Virol. 2000 Oct;74(20):9680-93
11000240
J Virol. 2001 Aug;75(15):7198-201
11435602
J Virol. 2001 May;75(9):4459-66
11287601
Nat Genet. 1997 Jan;15(1):74-7
8988172
Mol Cell Biol. 2000 Nov;20(21):8244-53
11027293
Oncogene. 2002 Aug 1;21(33):5088-96
12140759
Oncogene. 2003 Sep 4;22(38):5938-45
12955072
Nature. 2001 May 24;411(6836):494-8
11373684
EMBO J. 1991 Dec;10(13):4129-35
1661671
BMC Bioinformatics. 2003 Aug 20;4:32
12930545
Nature. 1996 Mar 7;380(6569):79-82
8598912
Oncogene. 2001 Aug 2;20(34):4740-9
11498796
J Gen Virol. 1999 Jun;80 ( Pt 6):1513-1517
10374970
Cancer Res. 1996 Oct 15;56(20):4620-4
8840974
Genomics. 1998 Jan 1;47(1):101-7
9465301
J Biol Chem. 1999 Jun 25;274(26):18785-92
10373495
J Biol Chem. 2005 Mar 18;280(11):10807-16
15655249
Nat Genet. 1997 Sep;17(1):75-8
9288101
Semin Cancer Biol. 2003 Feb;13(1):59-67
12507557
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6347-52
12746500
J Virol. 2003 Jun;77(12):6957-64
12768014
J Virol. 2001 May;75(9):4467-72
11287602
Nat Genet. 1997 Jan;15(1):70-3
8988171
J Virol. 1989 Oct;63(10):4417-21
2476573
Nucleic Acids Res. 2003 Jan 1;31(1):28-33
12519941
J Virol. 2004 Apr;78(7):3533-41
15016876
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2563-7
7708685
J Virol. 1994 May;68(5):2811-21
8151752
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8211-6
12821782
Exp Cell Res. 2002 Jul 15;277(2):173-82
12083799
Cell. 2000 Jan 7;100(1):57-70
10647931
Nat Rev Cancer. 2002 May;2(5):342-50
12044010
Oncogene. 2002 Sep 5;21(39):6041-8
12203116
J Biol Chem. 1998 Dec 18;273(51):34302-9
9852095
EMBO J. 1989 Dec 1;8(12):3905-10
2555178
J Virol. 2001 Jun;75(12):5559-66
11356963
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4412-7
9114003
Oncogene. 2000 Nov 2;19(46):5270-80
11077444
Virology. 2002 Jul 20;299(1):72-87
12167343
Genomics. 1997 Apr 15;41(2):263-6
9143503
Mol Cell Biol. 2003 Dec;23(24):9094-103
14645521
Mol Cell Biol. 1999 Jan;19(1):733-44
9858596
Oncogene. 2001 Nov 26;20(54):7888-98
11753671
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8058-63
9653139
Genes Dev. 2000 Dec 1;14(23):3065-73
11114894
J Gen Virol. 2000 Nov;81(Pt 11):2617-2623
11038372